Status
Conditions
Treatments
About
The primary purpose of the study is to compare therapy with antipsychotic medication (antipsychotic monotherapy or antipsychotic combination) versus no antipsychotic medication, and antipsychotic monotherapy versus antipsychotic combination, regarding time to psychiatric rehospitalization, in participants with a psychotic disorder (that is, schizophrenia, schizotypal disorders, schizoaffective disorders, persistent or acute or induced or non-organic delusional disorders, recurrent depressive disorder with psychotic symptoms).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Due to data management constraint, the participants with multiple or temporary identifiers in the database (indistinguishable in database) will be excluded. This happens with twins or migrants, for example.
579,728 participants in 1 patient group
Loading...
Central trial contact
Eisai Medical Information
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal